Net margin is calculated as Net Income divided by its Revenue. Accendra Health's Net Income for the
three
months ended in Mar. 2026 was $-6 Mil. Accendra Health's Revenue for the
three
months ended in Mar. 2026 was $628 Mil. Therefore, Accendra Health's net margin for the quarter that ended in Mar. 2026 was -1.03%.
The historical rank and industry rank for Accendra Health's Net Margin % or its related term are showing as below:
ACH'
s Net Margin % Range Over the Past 10 Years
Min: -39.85 Med: -0.23 Max: 2.26
Current: -39.84
ACH's Net Margin % is ranked worse than 91.6% of 119
companies
in the Medical Distribution industry
Industry Median: 1.53
vs ACH: -39.84
Accendra Health (NYSE:ACH) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Accendra Health Net Margin % Related Terms
Accendra Health Net Margin % Historical Data
* Premium members only.
The historical data trend for Accendra Health's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Accendra Health's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's Net Margin % distribution charts can be found below:
* The bar in red indicates where Accendra Health's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health (ACH) has a Net Margin % of -1.03% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Accendra Health and its competitors. According to the industry distribution chart, Accendra Health ranks #109 out of 119 companies in the Medical Distribution industry, placing it in the top 91.6%.
Is Accendra Health's Net Margin % too high?
Accendra Health's current Net Margin % is -1.03%. Based on the distribution chart, Accendra Health ranks #109 out of 119 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Accendra Health has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Net Margin % compare to EDAP and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #109 out of 119 companies for Net Margin %. This places Accendra Health in the lower half of its industry. The industry median Net Margin % is 1.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.53, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Accendra Health and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current Net Margin % is -1.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $3.20 — trading 36.3% below its estimated fair value. The current Net Margin % is -1.03%. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Accendra Health (ACH), the current Net Margin % is -1.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.20 is trading 36.3% below its estimated GF Value™ of $5.02.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
Net Margin %: -1.03%
GF Value™: $5.02 vs. price of $3.20 (36.3% below fair value)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score
Get the complete analysis for ACH
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
